News Releases

<< Back
Faced with Global Acetonitrile Shortage, Analytical Labs Turn to ACQUITY UPLC to Reduce Acetonitrile Use by at least 70 Percent

MILFORD, Mass., Dec. 16 /PRNewswire-FirstCall/ -- With the analytical industry experiencing its most severe acetonitrile shortage in history, pharmaceutical, food, environmental and chemical industries are all searching for solutions to maintain their mission critical laboratory productivity. Waters Corporation (NYSE: WAT), working with its key customers, today estimated that replacing traditional high performance LC (HPLC) with Waters(R) ACQUITY(R) UltraPerformance LC(R) (UPLC(R)) reduces acetonitrile consumption by at least 70 percent without compromising productivity and performance.

"The time for ACQUITY UPLC adoption has never been clearer," said Rohit Khanna, Vice President of Global Marketing for the Waters Division. "Laboratory-dependent businesses and government agencies around the world are facing difficult decisions because there is simply not enough acetonitrile available to efficiently run their labs using traditional liquid chromatography technology. As these organizations evaluate their options, the innovations behind UPLC technology provide the best solution to today's crisis and safeguarding against future risk."

The ACQUITY UPLC System allows scientists to perform required analysis, such as quality assurance and quality control tests, using less resource than HPLC. Because the system operates with a wider velocity range, higher flow rates, and greater backpressures, UPLC uses significantly less solvent, including acetonitrile. The result is the ability to maintain or improve lab productivity and performance, with reduced costs and reduced external pressures associated with the current acetonitrile shortages.

For more information on ACQUITY UPLC, method validation, and related case studies, please visit: http://www.waters.com/acn.

About Waters Corporation: (http://www.waters.com)

Waters Corporation creates business advantage for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, UltraPerformance LC, UPLC, and ACQUITY UPLC are trademarks of Waters Corporation.

Investor Contact:
Gene Cassis
Corporate Vice President, Worldwide Business Development
Waters Corporation

Ph: 508-482-2349

Media Contact:
Brian J. Murphy
Public Relations Manager
Waters Corporation
Ph: 508-482-2614